Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2005-02-15
2005-02-15
Krass, Frederick (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S023000, C514S077000, C514S556000, C514S578000, C514S824000, C514S834000, C514S457000, C514S571000, C514S161000, C514S165000, C514S554000, C514S423000, C514S460000, C424S400000, C424S443000, C424S422000, C424S464000, C424S094640
Reexamination Certificate
active
06855734
ABSTRACT:
Pharmaceutical uses of glycine betaine, such as for the treatment of thromboses not induced by hyperhomocystenemia or homocystinuria, of blood disorders, such as blood coagulation, thrombi formation.
REFERENCES:
patent: 5880098 (1999-03-01), Haussinger
patent: 0347864 (1989-06-01), None
patent: 0781554 (1996-07-01), None
patent: 210122 (1992-09-01), None
patent: 9515750 (1993-12-01), None
patent: 9738685 (1996-04-01), None
patent: 9706795 (1996-08-01), None
patent: 9819690 (1996-11-01), None
patent: WO 9706795 (1997-02-01), None
patent: 0025764 (1998-10-01), None
Mar et al., Betaine in wine: answer to the French paradox., Med Hypothesis, Nov. 1999.; 53(5):383-5, see abstract.*
Changes in blood coagulation in experimental subacute poisoning with p-chlorobenzene. The influence of some lipotropic factors, Folia Medica (Naples), 1960, 43, 259-66, see: abstract.*
Article from Entrez-PubMed web page entitled: SR 121787, a new orally active fibrinogen receptor antagonist.
Article from Entrez-PubMed web page entitled: Antiaggregatory, antithrombotic effects of MS-180, a novel platelet glycoprotein llb/llla receptor antagonist.
Article from Entrez-PubMed web page entitled: Antithrombotic effects of MK-0852, a platelet fibrinogent receptor antagonist, in canine models of thrombosis.
Article from Entrez-PubMed web page entitled: SR 121787, Prevention of thrombosis and enhancement of thrombolysis in rabbits by SR 121787, a glycoprotein ll/lll antagnoist.
Article from Entrez-PubMed web page entitled: Role of platelets in thrombosis and hemostasis.
Article from Entrez-PubMed web page entitled: Nonpeptide glyocprotein llb/llla inhibitors. 5. Antithrombotic effects of MK-0383.
Article from Entrez-PubMed web page entitled: The in vitro and in vivo pharmacological profiles of a platelet glycoprotein llb/llla antagonist, NSL-9403.
Article from Entrez-PubMed web page entitled: antiplatelet and antithrombotic effects of orbofiban, a new orally active GPllb/llla antagonist, in guinea pigs.
XP-002123170 Database Chemabs 'Online!; Chemical Abstracts Service, Columbus, OH Zapadnyuk, B.I. et al.: “Bile-secretory effect of trimethylglycine in normal and atherosclerotic animals of different ages” retrieved from STN Database accession No. 107:190742 HCA abstract & Byull. Eksp. Biol. Med. (1987), 104(7), 30-2.
XP002123171 Database Chembas 'Online!; Chemical ABstracts Service, Columbus, OH Panteleimonova, T.N. et al.: “Effect of trimethylglycine on lipid metabolism in rabbits with experimental atheroscrlerosis” retrieved from STN Database accession No. 99:99080 HCA abstract & Farmakol. Toksikol. (Moscow) (1983), 46(4), 83-5.
XP-000853747 Fazio B et al: “Treatment of human atherosclerosis with betaine.” Minerva Med, (Apr. 25, 1961) 52 1511-6., the whole document.
XP-002123167 P.H. List et al.: “Hagers Handbuch Der Pharmazeutischen Praxis” 1972, Springer-Verlag, Berlin Heidelberg, New York, p. 431.
XP00085853 “Betaine for homoceystinuria.” Medical Letter on Drugs and Therapeutics, (1997) 39/993 (12)., the whole document.
Xp000853897 Wilcken D E et al: “The natural history of vascular disease in homocystinuria and the effects of treatment.” Journal Of Inherited Metabolic Disease, (Jun. 1997)20 (2) 295-300., the whole document.
XP-002123168 J.E.F. Reynolds: “Martindale, The Extra Pharmacopoeia” 1996, Royal Pharmaceutical Society, London “Betaine hydrochloride” p. 1679.
XP002123169 “the merck index” 1996, Merck & Co, Whithouse Stations, NJ “Betain” p. 198.
Matthews, et al.; An indirect response model of homocysteine suppression by betain: optimising the dosage regimen of betaine in homocystinuria: 2002 Blackwell Science Ltd Br; J Clin Pharmacol, 54, 140-146.
Schwahn et al.; Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria; 2003 Blackwell Science Ltd Br; J Clin Pharmacol, 55, 6-13.
Da Silva; Anticoagulants: to bleed or not to bleed, that is the question.; SUNY Upstate Medical University Syracuse, NY, USA; Semin Vasc Surg. Dec. 2002; 15(4): 256-67; PMID: 12478500 (PubMed- indexed for MEDLINE).
Silver; The caput medusae of hypercoagulability.; Department of Surgery, University of Missouri-Columbia, USA; Vasc Surg. Feb. 2000; 31 (2): 396-405; PMID: 10664508 (PubMed—indexed for MEDLINE).
Rogers; Hypercoagulable states.; Section of Endocrinology and Metabolism, West Virginia University Health Sciences Center.; W V Med J. Feb. 1993; 89(2): 61-3; PMID: 8442350 (PubMed—indexed for MEDLINE).
Marcel et al.; From Virchow to red cells (the unended quest).; Ric Clin Lab. 1983; 13 Suppl 3:71-81.; PMID: 6324327 (PubMed—indexed for MEDLINE).
Lasch; (Principles of drug prevention of thrombosis); (Article in German); Langenbecks Arch Chir. 1986, 369: 451-7; PMID: 3807563 (PubMed-indexed for MEDLINE).
Copy of a Chinese document (Homocysteine and Vascular Diseases) Subdivision of Foreign Medical Surgery, 1996. 23, 2 pages 91-93, as well as an English translation thereof. An English translation of BE 09900141 (sent via facsimile).
Hovey & Williams, LLP
Krass Frederick
Ostrup Clinton
LandOfFree
Glycine betaine and its use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycine betaine and its use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycine betaine and its use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3512276